A psychedelic trip to recovery: How psychedelics can help treat PTSD

published on January 20, 2022 by Christine Seo in The Ubyssey

The medicinal benefits of psychedelics, including MDMA, are currently being explored by researchers from both UBC campuses.

In 2015, The Ubyssey first published an article introducing the potential use of MDMA, also known as ecstasy, to treat symptoms of post-traumatic stress disorder (PTSD). In the seven years since, there has been increasing evidence showing the application of psychedelics in treating PTSD. The work of Dr. Zach Walsh and his colleagues from UBC Okanagan’s department of psychology, as well as research groups working in the Vancouver community, are at the forefront of this research.

‘A debilitating disorder’

PTSD is a condition characterized by an onset of symptoms after a traumatic event. Some of these symptoms include intrusive memories and flashbacks, negative emotions, irritability and hyperreactivity, according to the government of Canada’s “Federal framework on posttraumatic stress disorder.” The document details that the diagnosis of PTSD requires symptoms that make it harder for the individual to function and be present for longer than one month…

View the full article